Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01896479 |
| Title | A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer (EXAMINER) |
| Acronym | EXAMINER |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Exelixis |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | SWE | ROU | POL | NLD | ITA | ISR | HUN | HRV | FRA | ESP | CAN | AUS |